ELAVL1 and chronic myelogenous leukemia, BCR-ABL1 positive: HuR-miR-184. In chronic myelogenous leukemia (CML), HuR and miR-184 compete for the binding to MDR1 (Multidrug Resistance Protein 1) 3′UTR and thus play a major role in chemosensitivity [82].